Lupus (SLE): open trials in Italy

8 open trials have a site in Italy. Registry data; only the trial team decides who can take part.

NCT05039619
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Trial Treatment · Phase 2 · Hoffmann-La Roche
IRCCS Istituto Giannina Gaslini, Genoa · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Ospedale Pediatrico Bambino Gesù, Rome
Registry updated 2026-11-03
NCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Research · Bristol-Myers Squibb
Asst Degli Spedali Civili Di Brescia, Brescia · Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna, Ferrara · Universita Degli Studi Di Padova, Padova · Azienda Ospedaliera Ordine Mauriziano di Torino, Torino
Registry updated 2026-11-02
NCT07598396
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Trial Treatment · Phase 2 · Hoffmann-La Roche
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano · Ospedale San Giovanni Bosco, Turin
Registry updated 2026-10-19
NCT07629583
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Trial Treatment · Phase 1 · Genentech, Inc.
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-06
2022-500699-76-00
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-1)
Trial Treatment · Phase 3 · Bristol-Myers Squibb Services Unlimited Company
Azienda Ospedaliero Universitaria Pisana, Pisa · Universita' Degli Studi Di Verona, Verona
Registry updated 2026-09-21
NCT06527872
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Research · GlaxoSmithKline
GSK Investigational Site, Rozzano
Registry updated 2026-07-02
2024-518580-35-00
Steroid withdrawal in SLE
Trial Treatment · Phase 4 · Azienda Ospedaliero Universitaria Pisana
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia · Azienda Ospedaliero - Universitaria di Cagliari, Cagliari · University Hospital Of Ferrara, Ferrara · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliero Universitaria Pisana, Pisa
Registry updated 2025-11-19
NCT07215754
Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients
Research · University of Pisa
University of Pisa, Pisa
Registry updated 2025-10-10

All Lupus (SLE) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error